Aptamer Group and Mologic enter commercial partnership to develop aptamer-based SARS-CoV-2 rapid antigen test
Aptamer Group, the developer of diagnostic and therapeutic Optimer reagents, has entered a commercial partnership with Mologic, a leading developer and manufacturer of lateral flow and rapid diagnostic tests.